DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 19, 2007; DOI: 10.1124/dmd.107.018820


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.018820v1
36/3/604    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van de Kerkhof, E. G
Right arrow Articles by Groothuis, G. M.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van de Kerkhof, E. G
Right arrow Articles by Groothuis, G. M.M.


Received for publication September 12, 2007.
Revised December 18, 2007.
Accepted for publication December 18, 2007.

Induction of metabolism and transport in human intestine: Validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro

Esther G van de Kerkhof 1, Inge A de Graaf 1, Anna-Lena B Ungell 2, Geny M.M. Groothuis 1*

1 Groningen Research Institute for Pharmacy, University of Groningen 2 AstraZeneca R&D

* Address correspondence to: E-mail: g.m.m.groothuis{at}rug.nl

Abstract

Induction of drug enzyme activity in the intestine can strongly determine plasma levels of drugs. It is therefore important to predict drug-drug interactions in human intestine in vitro. We evaluated the applicability of human intestinal precision-cut slices for induction studies in vitro. Morphological examination and intracellular ATP levels indicated tissue integrity up to 24 h of incubation, whereas in proximal jejunum slices, the metabolic rate towards most substrates remained at 40-50% of initial values. In colon slices, the P450 conversions were below the detection limit, but conjugation rates remained relatively constant during incubation. The inducibility of drug metabolizing enzymes and PGP was evaluated using prototypical inducers for five induction pathways. {beta}-Naphthoflavone (AhR ligand) induced CYP1A1 (132-fold in colon, 362-fold in proximal jejunum) and UGT1A6 mRNA (9.8-fold in colon, 3.2-fold in proximal jejunum). In proximal jejunum, rifampicin (PXR ligand) induced CYP3A4 (5.2-fold), CYP2B6 (2-fold) UGT1A6 (2.2-fold) and MDR1/ABCB1 mRNA (2.7-fold), whereas 6{beta}-hydroxytestosterone formation (CYP3A4) increased 2-fold. In colon, RIF induced UGT1A6 32-fold and MDR1 2.2-fold. Dexamethasone (GR and PXR ligand) induced CYP3A4 mRNA (3.5-fold) and activity (5-fold) in proximal jejunum. Phenobarbital (CAR activator) induced CYP3A4 (4.1-fold, only in jejunum), CYP2B6 (4.9-fold in colon, 2.3-fold in proximal jejunum) and MDR1/ABCB1 mRNA and CYP3A4 activity (2-fold only proximal jejunum). Quercetin (Nrf2 activator) induced UGT1A6 mRNA (6.7-fold in colon, 2.2-fold in proximal jejunum). In conclusion, this study shows that human intestinal precision-cut slices are useful to study induction of drug metabolising enzymes and transporters in the human intestine.


Key words: CYP induction, cytochrome P450 regulation, drug-drug interactions, enzyme induction, extrahepatic drug metabolism, in vitro-in vivo prediction, phase II drug metabolism





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.